Paxton Bach

1.9k total citations · 1 hit paper
72 papers, 1.2k citations indexed

About

Paxton Bach is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Toxicology. According to data from OpenAlex, Paxton Bach has authored 72 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Public Health, Environmental and Occupational Health, 40 papers in Epidemiology and 13 papers in Toxicology. Recurrent topics in Paxton Bach's work include Opioid Use Disorder Treatment (44 papers), Substance Abuse Treatment and Outcomes (24 papers) and HIV, Drug Use, Sexual Risk (22 papers). Paxton Bach is often cited by papers focused on Opioid Use Disorder Treatment (44 papers), Substance Abuse Treatment and Outcomes (24 papers) and HIV, Drug Use, Sexual Risk (22 papers). Paxton Bach collaborates with scholars based in Canada, United States and United Kingdom. Paxton Bach's co-authors include Daniel M. Hartung, Sarah Kidd, Yat Chow, Karen H. Bartlett, James W. Kronstad, Sunny Mak, Simeon D. Kimmel, Nicholas Chadi, Huiming Chen and Payel Roy and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Paxton Bach

57 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study

2024 45 citations Amanda Slaunwhite, Jeong Eun Min et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paxton Bach Canada	15	668	529	222	142	109	72	1.2k
Evan S. Schwarz United States	19	353 0.5×	460 0.9×	84 0.4×	134 0.9×	156 1.4×	69	1.6k
Phil Wiffen United Kingdom	8	176 0.3×	105 0.2×	200 0.9×	129 0.9×	203 1.9×	39	1.4k
Eric I. Rosenberg United States	15	121 0.2×	250 0.5×	38 0.2×	172 1.2×	176 1.6×	44	1.1k
Evan Tzanis United States	23	392 0.6×	217 0.4×	350 1.6×	44 0.3×	132 1.2×	68	1.6k
Perrine Roux France	24	1.1k 1.6×	625 1.2×	587 2.6×	159 1.1×	74 0.7×	117	1.8k
Giovanni Piccaro Italy	16	277 0.4×	42 0.1×	344 1.5×	70 0.5×	40 0.4×	22	787
Michael A. Überall Germany	18	555 0.8×	143 0.3×	122 0.5×	235 1.7×	94 0.9×	86	1.5k
Desiree Mustaquim United States	15	571 0.9×	249 0.5×	298 1.3×	79 0.6×	31 0.3×	25	994
Remington L. Nevin United States	19	121 0.2×	182 0.3×	100 0.5×	63 0.4×	13 0.1×	50	754
Chiara Mameli Italy	18	221 0.3×	286 0.5×	87 0.4×	205 1.4×	3 0.0×	74	1.3k

Countries citing papers authored by Paxton Bach

Since Specialization

Citations

This map shows the geographic impact of Paxton Bach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paxton Bach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paxton Bach more than expected).

Fields of papers citing papers by Paxton Bach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paxton Bach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paxton Bach. The network helps show where Paxton Bach may publish in the future.

Co-authorship network of co-authors of Paxton Bach

This figure shows the co-authorship network connecting the top 25 collaborators of Paxton Bach. A scholar is included among the top collaborators of Paxton Bach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paxton Bach. Paxton Bach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Young, Samantha, Nadia Fairbairn, Zishan Cui, et al.. (2025). Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: A retrospective cohort study from British Columbia, Canada. Addiction. 120(6). 1184–1194. 1 indexed citations

Bach, Paxton, M. Eugenia Socías, Nadia Fairbairn, et al.. (2025). Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020. Drug and Alcohol Dependence. 273. 112703–112703. 2 indexed citations

Hossain, Md. Belal, Jeong Eun Min, Mohammad Ehsanul Karim, et al.. (2025). Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelines. BMJ Open. 15(3). e095198–e095198.

Rosic, Tea, Myanca Rodrigues, Paxton Bach, et al.. (2025). Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study. Drug and Alcohol Dependence Reports. 16. 100368–100368.

Min, Jeong Eun, Fahmida Homayra, Paxton Bach, et al.. (2025). Comparative effectiveness of maintenance doses of opioid agonist treatment among individuals with opioid use disorder: a target trial emulation protocol using a population-based observational study. BMJ Open. 15(8). e098439–e098439.

Nolan, Seonaid, et al.. (2025). Intravenous Fentanyl for Symptom Management in Hospitalized Patients With Refractory Opioid Withdrawal: A Retrospective Cohort Study. Journal of Addiction Medicine. 19(4). 449–455.

Hossain, Md. Belal, Jeong Eun Min, Micah Piske, et al.. (2025). Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada. BMJ Open. 15(9). e098990–e098990.

Slaunwhite, Amanda, Jeong Eun Min, Heather Palis, et al.. (2024). Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. BMJ. 384. e076336–e076336. 45 indexed citations breakdown →

Khalili, Malahat, Paxton Bach, Alexis Crabtree, et al.. (2024). Management of Amphetamine and Methamphetamine Use Disorders: A Systematic Review and Network Meta-analysis of Randomized Trials. International Journal of Mental Health and Addiction. 23(6). 4768–4786. 1 indexed citations

10.

Sharafi, Heidar, Sarah Drouin, Stephanie Coronado‐Montoya, et al.. (2023). Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials. Addiction. 119(2). 211–224. 9 indexed citations

11.

Sharafi, Heidar, Arash Bahremand, Sarah Drouin, et al.. (2023). Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials. Drug and Alcohol Dependence. 253. 111018–111018. 3 indexed citations

12.

Bahji, Anees, M. Eugenia Socías, Paxton Bach, & M‐J Milloy. (2023). Implications of Cannabis Legalization on Substance-Related Benefits and Harms for People Who Use Opioids: A Canadian Perspective. Cannabis and Cannabinoid Research. 8(5). 699–702. 1 indexed citations

13.

Bach, Paxton, Lianping Ti, Kanna Hayashi, et al.. (2023). Trends in cocaine and crystal methamphetamine injection over time in a Canadian setting between 2008 and 2018. Journal of Substance Use and Addiction Treatment. 151. 208982–208982. 1 indexed citations

14.

Crispo, James A. G., Paxton Bach, Dominique R. Ansell, et al.. (2022). Amphetamine-related care in the USA, 2003–2014: cross-sectional analyses examining inpatient trends and factors associated with hospitalisation outcomes. BMJ Open. 12(9). e059898–e059898. 1 indexed citations

15.

Bahji, Anees, M. Eugenia Socías, & Paxton Bach. (2022). Cases: Multiorgan failure in a 38-year-old man with recent consumption of kratom, an atypical opioid. 2(1). 100088–100088.

16.

Bahji, Anees, Paxton Bach, Marlon Danilewitz, et al.. (2022). Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta‐analysis. Addiction. 117(10). 2591–2601. 14 indexed citations

17.

Joudrey, Paul J., Nicholas Chadi, Payel Roy, et al.. (2020). Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study. Drug and Alcohol Dependence. 211. 107968–107968. 88 indexed citations

18.

Schwartz, Ilan S., Paxton Bach, Anna Majury, et al.. (2014). Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates. The International Journal of Tuberculosis and Lung Disease. 18(7). 787–792. 10 indexed citations

19.

Bach, Paxton, et al.. (2011). Effects of methylmercury on the secretion of pro-inflammatory cytokines from primary microglial cells and astrocytes. NeuroToxicology. 33(2). 229–234. 29 indexed citations

20.

Ghoreishi, Mehran, et al.. (2009). Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol. The Journal of Immunology. 182(10). 6071–6078. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact